cytarabine has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crowder, RJ; Freeman, RS; Lipscomb, EA; Sarmiere, PD | 1 |
| Bedner, E; Darzynkiewicz, Z; Du, L; Smolewski, P; Traganos, F | 1 |
| Billi, AM; Bortul, R; Cocco, L; Conte, R; Manzoli, L; Martelli, AM; Ruggeri, A; Tabellini, G; Tazzari, PL | 1 |
| Gale, RE; Grandage, VL; Khwaja, A; Linch, DC | 1 |
| Allan, EK; Eaves, CJ; Elliott, MA; Godden, JL; Graham, SM; Holyoake, TL; Jørgensen, HG; Mountford, JC; Richmond, L | 1 |
| Cebula, B; Janus, A; Linke, A; Robak, T; Smolewski, P | 1 |
6 other study(ies) available for cytarabine and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
| Article | Year |
|---|---|
Expression of the SM-20 gene promotes death in nerve growth factor-dependent sympathetic neurons.
Topics: Animals; Apoptosis; Cells, Cultured; Chromones; Cytarabine; DNA-Binding Proteins; Embryo, Mammalian; Enzyme Inhibitors; Gene Expression; Hypoxia-Inducible Factor-Proline Dioxygenases; Immediate-Early Proteins; Morpholines; Nerve Growth Factors; Neurons; Phosphoinositide-3 Kinase Inhibitors; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Superior Cervical Ganglion; Transfection | 1999 |
Selective protection of mitogenically stimulated human lymphocytes but not leukemic cells from cytosine arabinoside-induced apoptosis by LY294002, a phosphoinositol-3 kinase inhibitor.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Cell Cycle; Cell Division; Chromones; Cyclins; Cytarabine; Enzyme Activation; Enzyme Inhibitors; Flow Cytometry; Humans; Immunoenzyme Techniques; Leukemia; Lymphocytes; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Phytohemagglutinins; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Tumor Cells, Cultured; Up-Regulation | 2001 |
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
Topics: Antineoplastic Agents; bcl-Associated Death Protein; Blotting, Western; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspases; Chromones; Cytarabine; Cytochrome c Group; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; HL-60 Cells; Humans; Inhibitor of Apoptosis Proteins; Inositol; Intracellular Signaling Peptides and Proteins; Isoenzymes; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphoric Monoester Hydrolases; Phosphorylation; Protein Kinase C; Protein Kinase C-theta; Protein Serine-Threonine Kinases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Radiation, Ionizing; Ribosomal Protein S6 Kinases, 70-kDa; Transfection; Tretinoin; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases | 2003 |
PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways.
Topics: Acute Disease; ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Animals; Antigens, CD; Antigens, CD34; Antimetabolites, Antineoplastic; Cell Survival; Chromones; Cytarabine; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Leukemia, Myeloid; MAP Kinase Signaling System; Membrane Glycoproteins; Morpholines; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2005 |
Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Chromones; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Imatinib Mesylate; Lactams, Macrocyclic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Morpholines; Piperazines; Piperidines; Pyridines; Pyrimidines; Rifabutin | 2005 |
Rapamycin, the mTOR kinase inhibitor, sensitizes acute myeloid leukemia cells, HL-60 cells, to the cytotoxic effect of arabinozide cytarabine.
Topics: Adaptor Proteins, Signal Transducing; Caspase 3; Cell Cycle; Cell Cycle Proteins; Cell Death; Cell Proliferation; Cell Survival; Chromones; Cyclins; Cytarabine; Drug Synergism; Enzyme Inhibitors; Gene Expression; HL-60 Cells; Humans; Membrane Potential, Mitochondrial; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Phosphoproteins; Protein Kinases; Ribosomal Protein S6 Kinases, 70-kDa; Sirolimus; TOR Serine-Threonine Kinases | 2009 |